Previous 10 | Next 10 |
Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU Development PR Newswire As previously announced, planning is underway with FDA to advance ibezapo...
NEW YORK, Feb. 23, 2024 (GLOBE NEWSWIRE) -- FMW Media Work announces that its "New to The Street Leadership," Powered by Sector SPDR ETFs , will air on Bloomberg TV as sponsored programming on Saturday, February 24, 2024, at 6:30 PM ET, and the "New to The Street" business show will air o...
NEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) -- FMW Media Works Corp.'s New to the Street, a nationally broadcasted business television production, announces airing Episode 556 on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PT. New to The Street's Episode 556 line-up...
NEW YORK, Feb. 02, 2024 (GLOBE NEWSWIRE) -- FMW Media's New to The Street is airing its national TV show on the FOX Business Network on Monday, February 5, 2024, at 10:30 PM. New to The Street's 553rd episode features the following five (5) corporate interviews: 1). Vacation...
NEW YORK, Feb. 01, 2024 (GLOBE NEWSWIRE) -- FMW Media's New to The Street TV announces the broadcasting of its business show airing on Bloomberg TV as sponsored programming tonight, Thursday, February 1, 2024, at 9:30 PM PT. New to The Street's TV episode #552 will air the f...
Acurx Announces Positive Extended Clinical Cure Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients PR Newswire In the Phase 2b trial, 100% (5 of 5) of ibezapolstat-treated patients who agreed to observation for up to three months following Clinical Cure of ...
NEW YORK, Jan. 26, 2024 (GLOBE NEWSWIRE) -- FMW Media's New to The Street , a national TV show, announces episode 551, airing on the FOX Business Network on Monday, January 29, 2024, at 10:30 PM PT. New to The Street's 551st episode line-up features the following Five (5) Co...
Acurx Pharmaceuticals to Present at the Microcap Conference, January 31, 2024 - February 1, 2024 PR Newswire STATEN ISLAND, N.Y. , Jan. 23, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company") (NASDAQ: "ACXP"), a late-stage biopharmace...
2024-01-22 12:04:50 ET Summary Acurx shares opened ~25% lower on Jan 17th, after releasing positive data suggesting its C. diff antibiotic outperformed standard treatment in restoring the gut microbiome. The decline in share price since then may be due to misaligned investor expec...
NEW YORK, Jan. 19, 2024 (GLOBE NEWSWIRE) -- FMW Media Works Corp.'s New to the Street, a nationally broadcasted business television production, announces airing episode 550 on the FOX Business Network , Monday, January 22, 2024, at 10:30 PM PT. New to The Street's 550 th TV epis...
News, Short Squeeze, Breakout and More Instantly...
Acurx Pharmaceuticals Inc. Company Name:
ACXP Stock Symbol:
NASDAQ Market:
Acurx Pharmaceuticals Inc. Website:
USPTO Grants Acurx Pharmaceuticals New Patent for Ibezapolstat to Treat CDI While Reducing Recurrence of Infection and Improving Health of the Gut Microbiome PR Newswire STATEN ISLAND, N.Y. , July 17, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ:...
Acurx Pharmaceuticals, Inc. to Discuss Second Quarter 2024 Financial Results on August 9, 2024 Conference Call and Provide Business Update PR Newswire STATEN ISLAND, N.Y. , July 16, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "...
Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results for CDI at Scientific Conference PR Newswire Additional analyses of clinical and microbiological data from the Phase 2b segment show favorable gut microbiome changes including inc...